Corticosteroid use in patients with inflammatory bowel diseases: A real-life sub-analysis of the Italian DICE study
Despite the availability of novel treatments such as immunomodulators and biologic therapies, corticosteroids (CS) still play an important role in inducing remission of chronic inflammatory bowel diseases (IBDs) including Crohn's disease (CD) and ulcerative colitis (UC) [1]. Indeed, while steroids are routinely used in IBD for the management of acute flares, some patients receive prolonged exposure to these drugs and the long-term administration of CS is associated with several side-effects and a lack of efficacy in maintaining remission [2,3].
Source: Digestive and Liver Disease - Category: Gastroenterology Authors: Francesco Simone Conforti, Davide Giuseppe Ribaldone, Mauro Mastronardi, Lorenzo Gemignani, Paride Maddalena, Anna Viola Tags: Correspondence Source Type: research
More News: Corticosteroid Therapy | Crohn's Disease | Gastroenterology | Inflammatory Bowel Disease | Italy Health | Liver | Liver Disease | Study | Ulcerative Colitis | Urology & Nephrology